For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD sends comments to FDA on clinical outcome assessments
Published: Sep 27, 2022
Tagged in: Advancing Rare Disease Research and Regulatory Science, Patient Focused Drug Development